Cargando…

Development and validation of a novel fibroblast scoring model for lung adenocarcinoma

The interaction between cancer-associated fibroblasts (CAFs) and the tumor microenvironment (TME) is a key factor for promoting tumor progression. In lung cancer, the crosstalk between CAFs and malignant and immune cells is expected to provide new directions for the development of immunotherapy. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shiyou, Gu, Xuyu, Zhang, Wentian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444064/ https://www.ncbi.nlm.nih.gov/pubmed/36072807 http://dx.doi.org/10.3389/fonc.2022.905212

Ejemplares similares

Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma
por: Wang, Cailian, et al.
Publicado: (2021)

Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma
por: Gu, Xuyu, et al.
Publicado: (2022)

Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma
por: Yang, Lingge, et al.
Publicado: (2022)

The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma
por: Zhao, Guojie, et al.
Publicado: (2022)

Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma
por: Li, Qi, et al.
Publicado: (2021)

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics
por: Li, Huijun, et al.
Publicado: (2022)

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

Development and validation of a nomogram model for lung cancer based on radiomics artificial intelligence score and clinical blood test data
por: Hu, Wenteng, et al.
Publicado: (2023)

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2023)

Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma
por: Gu, Xuyu, et al.
Publicado: (2022)

Development and Validation of a Prognostic Index Based on Genes Participating in Autophagy in Patients With Lung Adenocarcinoma
por: Wu, Zi-Xuan, et al.
Publicado: (2022)

Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma
por: Shu, Long, et al.
Publicado: (2022)

A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma
por: Peng, Haijun, et al.
Publicado: (2023)

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Li, Xinyan, et al.
Publicado: (2022)

Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score
por: Chen, Yadong, et al.
Publicado: (2023)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

A Novel Translational Ovine Pulmonary Adenocarcinoma Model for Human Lung Cancer
por: Gray, Mark E., et al.
Publicado: (2019)

Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator
por: Li, Xinyan, et al.
Publicado: (2022)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study
por: Cai, Yong-sheng, et al.
Publicado: (2022)

Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma
por: Li, Juan, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022)

Development and Validation of a Radiomics Nomogram for Differentiating Pulmonary Cryptococcosis and Lung Adenocarcinoma in Solitary Pulmonary Solid Nodule
por: Zhao, Jiabi, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2023)

Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
por: Li, Jingyang, et al.
Publicado: (2022)

Efficacy of thoracoscopic segmentectomy versus lobectomy in the treatment of early invasive lung adenocarcinoma: a propensity score matching study
por: Ding, Congyi, et al.
Publicado: (2023)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes
por: Jiang, Hui-zhong, et al.
Publicado: (2022)

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2022)

Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis
por: He, Yi, et al.
Publicado: (2021)

Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung
por: Chen, Zhiyong, et al.
Publicado: (2022)

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Construction and validation of a novel nomogram to predict cancer-specific survival in patients with gastric adenocarcinoma
por: Nie, Guole, et al.
Publicado: (2023)

Identification of endoplasmic reticulum stress-related lncRNAs in lung adenocarcinoma by bioinformatics and experimental validation
por: Xin, Tong, et al.
Publicado: (2023)

Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma
por: Lu, Lu, et al.
Publicado: (2021)

Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures
por: Lu, Fei, et al.
Publicado: (2022)

Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
por: Wang, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6jf3b40lun5cmia0jkkh0uqb01